Big pharma, Partnering, Pharma

Biogen Idec forms a pharma alliances with Proteostasis Therapeutics

Posted on 10 December 2013

Tags: , , ,

A pharma alliances is created between Biogen Idec and Proteostasis Therapeutics for Alzheimer's treatment. Proteostasis Therapeutics has entered into a worldwide pharma alliances with Biogen Idec to research and develop therapeutic candidates based on the inhibition of Usp14.

This collaboration combines Proteostasis Therapeutics’ proprietary scientific platform and preclinical work on protein degradation with Biogen Idec’s neurodegenerative disease research and clinical development capabilities.

Preclinical research has shown that the inhibition of Usp14 modulates proteasome activity and increases the degradation rate of aggregation-prone proteins.

Proteostasis will receive an initial upfront payment from Biogen Idec, along with an equity investment.

It is eligible for research funding support and future development and commercial milestones that could result in total payments of up to $200 million, as well as tiered royalties.

The companies will conduct preclinical research to identify lead compounds for clinical development.

At specified points in development, Proteostasis will have the option to receive potential milestones or opt in for global co-development and U.S. co-commercialization rights.

Read the full article at BusinessWire

For further deal information visit Current Agreements (subscription required)



Report: Alzheimer’s Disease Partnering

Report: Partnering Deals and Alliances with Biogen Idec

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter



Print Friendly, PDF & Email

Leave a Reply